# Endocrinology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Swami Vivekananda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI032-SYN
- Date: 2026-02-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rohan Lindqvist-Bose, MD
- Calendar frame: modern shifted

- Requested by: Anjali Thornbury-Mensah, MD

## Reason for consultation

Two months of thirst, frequent urination, tiredness and about 4 kg weight loss in a 35-year-old Hindu monk of South Asian ancestry with a BMI of 24.7 and a random glucose of 246 mg/dL, told of diabetes a year ago and never tested or treated except by diet. Please confirm and classify the diabetes with the fasting tests drawn on the morning of your visit, and advise on treatment that fits his mostly vegetarian monastic diet, his religious fasts and his frequent travel. **S**

## History

Swami Vivekananda, 35, a Hindu monk, is seen at the request of Dr. Thornbury-Mensah for two months of thirst, nocturia, tiredness and weight loss. He was told of diabetes a year ago and has managed it only by diet. He eats mostly vegetarian meals at his monastery, with fish at some, and keeps fasts twice a month and at major festivals; a few days ago a night-long waterless fast left him light-headed and very thirsty. He calls diabetes hereditary in his family. He prefers tablets to injections but will accept what is needed. **S**

## Examination

| System | Finding |
|---|---|
| General | Well and forthright; BMI 24.6; blood pressure 136/86, pulse 80 |
| Skin | No acanthosis nigricans; mucous membranes moist |
| Feet | Monofilament and vibration sense normal; pulses present |

BP 136/86 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 72.8 kg; BMI 24.6 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Thornbury-Mensah's intake note: random glucose 246 mg/dL; urine glucose 3+ without ketones; creatinine 0.96, eGFR 106; BMI 24.7; blood pressure 138/86. This morning, fasting: A1c 9.4 percent; plasma glucose 172 mg/dL; GAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL; urine albumin-to-creatinine ratio 46 mg/g; total cholesterol 214, HDL 36, triglycerides 228, LDL 132 mg/dL; ALT 38 U/L (FIB-4 0.6); TSH 1.8; vitamin B12 312 pg/mL. Home blood pressure average 136/86. Hemoglobin A1c: 9.4% (high); Glucose (fasting): 172 mg/dL (high); GAD65 antibodies: 1.2 [IU]/mL; C-peptide (fasting): 2.6 ng/mL; Urine albumin-to-creatinine ratio: 46 mg/g (high); Total cholesterol: 214 mg/dL (high); HDL cholesterol: 36 mg/dL (low); Triglycerides: 228 mg/dL (high); LDL cholesterol: 132 mg/dL (high); ALT: 38 U/L; TSH: 1.8 mIU/L; Vitamin B12: 312 pg/mL. All results are synthetic.

## Assessment

1. **Type 2 diabetes** (E11.65). Question 1: diabetes is confirmed by two abnormal results (A1c 9.4 percent, fasting glucose 172 mg/dL). GAD65 antibodies are negative and his fasting C-peptide is preserved, so this is type 2 diabetes; slowly progressive autoimmune diabetes is unlikely, though antibodies should be rechecked if he loses weight again or needs rapidly escalating treatment. Monogenic diabetes is unlikely without a clear three-generation pattern. In South Asians type 2 diabetes appears earlier and at lower BMI, with more insulin resistance for a given weight, which is why ADA screens Asian Americans from a BMI of 23. Question 2: insulin is not needed now. He has no ketosis, his own insulin secretion is good and the A1c is below 10 percent; his weight loss reflects glucose spilling into the urine and should stop with treatment. **S**
2. **Moderately increased albuminuria, first sample** (R80.9). Question 5: 46 mg/g on one sample, which hyperglycemia can raise; it needs two of three abnormal samples over three to six months before diabetic kidney disease is diagnosed. **S**
3. **Raised blood pressure** (R03.0). Clinic and home readings of about 136/86: with diabetes and albuminuria the target is below 130/80. **S**

## Recommendations

1. Question 3: start metformin extended-release with the evening meal, 500 mg for a week, then 1000 mg, rising to 2000 mg if tolerated; extended-release taken with the meal that ends a fast suits his fasts. A second tablet now would also be reasonable at this A1c, but starting with metformin and diet and reviewing in about five weeks is safe and is his preference. Avoid sulfonylureas, which cause hypoglycemia during fasts. A GLP-1 receptor agonist is not the first choice for a man who has just lost weight unintentionally and prefers tablets.
2. Once albuminuria is confirmed, add an SGLT2 inhibitor for kidney and heart protection, with clear rules: skip it on waterless fast days and stop it when unable to eat or drink.
3. Question 4: by IDF-DAR risk stratification, adapted from Ramadan to his fasts, his risk is moderate while glucose is high and low on metformin once it is steady. Fasts with fruit, milk and water are reasonable now; avoid waterless fasts until glucose is steady below 180 mg/dL, and then keep them short and drink well before and after; check glucose at midday and before breaking a fast; break it if glucose is below 70 or above 300 mg/dL, or if he is dizzy, confused or vomiting.
4. Medical nutrition therapy with a dietitian: a mostly vegetarian plan built on his monastery meals (dal, vegetables, whole grains and yogurt, with smaller portions of rice and sweets), respecting his choices; healthy plant-based diets are associated with better cardiometabolic risk in South Asians.
5. Question 5: if home blood pressure stays at or above 130/80, an ARB (losartan) rather than an ACE inhibitor; potassium and creatinine one to two weeks after starting; repeat the urine albumin twice over three to six months.
6. Question 6: A1c target below 7 percent, A1c every three months until at target; retinal photographs and a foot examination at diagnosis; vitamin B12 periodically on metformin; a moderate-intensity statin is reasonable at 35 with diabetes, South Asian ancestry, albuminuria and raised blood pressure; hepatitis B and pneumococcal vaccines.

## Strengths and supports

- Supports: his brother monks and disciples, who share his daily life; his faith and practice. He wants his care to fit his vows and his duties, and he alone decides it **S**

## Communication

Discussed with Dr. Thornbury-Mensah the same day. The results and the reasons for each recommendation were explained to Swami Vivekananda, including why his fasts and his diet are his to decide and how the plan adapts to them. He decides who else receives this note. **S**

## Follow-up

Endocrinology review in three months, or sooner if glucose stays above 250 mg/dL, ketones appear or he loses weight again; Dr. Thornbury-Mensah continues primary care and shares the monitoring. **S**

## Guideline basis

- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S27-S49)
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344) (2013), Annals of the New York Academy of Sciences
- Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021), International Diabetes Federation and the Diabetes and Ramadan International Alliance
- Bhupathiraju SN, et al. A healthy plant-based diet is favorably associated with cardiometabolic risk factors among participants of South Asian ancestry. Am J Clin Nutr 2022;116(4):1078-1090 (PMID 35731596) (2022), American Journal of Clinical Nutrition
